Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-18 Purchase | 2022-03-21 4:06 pm | NeuBase Therapeutics Inc. | NBSE | Branning Todd P. Chief Financial Officer | 10,000 | $1.81 | $18,100 | 30,000 (Direct) | View |
| 2022-03-16 Purchase | 2022-03-18 4:11 pm | NeuBase Therapeutics Inc. | NBSE | Branning Todd P. Chief Financial Officer | 20,000 | $1.68 | $33,600 | 20,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-16 Option Award | 2023-03-17 4:11 pm | N/A N/A | NeuBase Therapeutics Inc. | NBSE | Branning Todd P. Chief Financial Officer | 54,200 | $0 | 84,200 (Direct) | View |
| 2022-11-03 Option Award | 2022-11-04 5:00 pm | N/A 2032-11-03 | NeuBase Therapeutics Inc. | NBSE | Branning Todd P. Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-01-10 Option Award | 2022-01-10 7:19 pm | N/A 2032-01-10 | NeuBase Therapeutics Inc. | NBSE | Branning Todd P. Chief Financial Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-01-29 4:28 pm | N/A 2031-01-27 | Phathom Pharmaceuticals Inc. | PHAT | Branning Todd P. Chief Financial Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-07-13 Option Award | 2020-07-13 4:50 pm | N/A 2030-07-12 | Phathom Pharmaceuticals Inc. | PHAT | Branning Todd P. Chief Financial Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 8:08 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Branning Todd P. SVP and CFO | 249,339 | $0 | 249,339 (Direct) | View |
| 2020-01-22 Tax Withholding | 2020-01-23 5:42 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Branning Todd P. SVP and CFO | 7,311 | $5.13 | 73,075 (Direct) | View |
| 2020-01-22 Exercise | 2020-01-23 5:42 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Branning Todd P. SVP and CFO | 40,192 | $0 | 73,075 (Direct) | View |
| 2019-11-13 Option Award | 2019-11-14 5:26 pm | N/A 2029-01-22 | Amneal Pharmaceuticals Inc. | AMRX | Branning Todd P. SVP, Chief Financial Officer | 163,666 | $0 | 163,666 (Direct) | View |
| 2019-11-13 Disposition | 2019-11-14 5:26 pm | N/A 2029-01-22 | Amneal Pharmaceuticals Inc. | AMRX | Branning Todd P. SVP, Chief Financial Officer | 163,666 | $0 | 163,666 (Direct) | View |